Showing results (501-510 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|January 16, 2025
Statin Use With Immune Checkpoint Inhibitors and Survival in Nonsmall Cell Lung CancerMichael T Marrone, Joshua E Reuss, Anna Crawford, et al.
Clinical Lung Cancer|January 23, 2025
Phase I Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation-Supported Dose-Intensified Chemotherapy With Adebrelimab as First-Line Treatment for Extensive-Stage Small Cell Lung CancerMing Liu, Wenhui Guan, Xiaohong Xie, et al.
Clinical Lung Cancer|February 1, 2025
Immunotherapy for Early-Stage Non-Small Cell Lung Cancer: A Practical Guide of Current ControversiesWilliam J Phillips, Ashley Jackson, Biniam Kidane, et al.
Clinical Lung Cancer|December 7, 2024
Enhanced Recovery With Aggressive Ambulation Decreases Length of Stay in Lung Cancer SurgeryJu Ae Park, Duy Pham, Kasper Nilsson, et al.
Clinical Lung Cancer|December 5, 2024
Metrics for Perioperative Exercise in Patients Undergoing Lung Cancer Resection: A Systematic ReviewTyler W Stumm, Shady Mina, Olugbenga Okusanya, et al.
Clinical Lung Cancer|December 13, 2024
Clinical, Dosimetric and Radiomic Features Predictive of Lung Toxicity After (Chemo)RadiotherapyCécile Evin, Léo Razakamanantsoa, François Gardavaud, et al.
Clinical Lung Cancer|December 14, 2024
Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Nonsmall Cell Lung CancerDaniel M Libby, Laura J Libby, Xiaoyue Ma, et al.
Clinical Lung Cancer|February 28, 2025
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) PatientsAdriana P C Barrichello, Arielle Elkrief, Biagio Ricciuti, et al.
Clinical Lung Cancer|December 10, 2024
Impact of Lung Biomarker Testing on Out-Of-Pocket Costs for Metastatic Non-Small-Cell Lung CancerLaila A Gharzai, Sarah Bell, Divya M Gupta, et al.
Clinical Lung Cancer|August 28, 2024
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLCAlessandro Leonetti, Veronica Cervati, Roberta Minari, et al.
Pageof 234